Fürstenau, M.
Bahlo, J.
Fink, A. M.
Lange, E.
Dreger, P.
Dreyling, M.
Hess, G.
Ritgen, M.
Kneba, M.
Döhner, H.
Stilgenbauer, S.
Wendtner, C. M.
Goede, V.
Fischer, K.
Böttcher, S.
Hallek, M.
Eichhorst, B.
Article History
Received: 18 May 2019
Revised: 30 August 2019
Accepted: 30 September 2019
First Online: 14 October 2019
Compliance with ethical standards
:
: MF, EL, and PD declare that they have no competing interests. JB reports personal fees (travel support) from Roche. AMF reports personal fees (advisory board) from Janssen Pharmaceutical during the conduct of the study. MD reports personal fees from Acerta, Bayer, Gilead, Novartis, Sandoz, grants and personal fees from Celgene, Janssen, Roche, and grants from Mundipharma outside the submitted work. DGH reports personal fees from Janssen, grants and personal fees from Roche, personal fees from Abbvie, personal fees from Gilead, personal fees from Novartis, grants from Pfizer, personal fees from Morphosys, and grants and personal fees from Celgene. MR reports grants from Roche during the conduct of the study, and personal fees from Roche outside the submitted work. MK reports personal fees from Roche and AbbVie. SS reports grants, personal fees, and nonfinancial support from AbbVie, grants, personal fees, and nonfinancial support from Amgen, grants, personal fees, and nonfinancial support from AstraZeneca, grants, personal fees, and nonfinancial support from Celgene, grants, personal fees, and nonfinancial support from Gilead, grants, personal fees, and nonfinancial support from GSK, grants, personal fees, and nonfinancial support from Hoffmann-La Roche, grants, personal fees, and nonfinancial support from Janssen, grants, personal fees, and nonfinancial support from Novartis, grants, personal fees, and nonfinancial support from Pharmacyclics, and grants, personal fees, and nonfinancial support from Sunesis outside the submitted work. HD reports personal fees from Agios, AbbVie, Amgen, Astellas, Astex, Celator, Celgene, Janssen, Jazz, Novartis, Seattle Genetics, and Sunesis and research funding from AROG, Bristol Myers Squibb, Celgene, Novartis, Pfizer, and Sunesis. CMW reports grants and personal fees from Hoffmann-La Roche, grants and personal fees from Mundipharma during the conduct of the study, grants and personal fees from Hoffmann-La Roche, grants and personal fees from Mundipharma, grants and personal fees from Janssen-Cilag, grants and personal fees from AbbVie, grants and personal fees from Gilead, grants and personal fees from Novartis, grants and personal fees from Celgene, and grants and personal fees from MorphoSys outside the submitted work. VG reports personal fees from Roche, personal fees from Janssen, personal fees from Gilead, personal fees from AbbVie, outside the submitted work. KF reports personal fees (travel support) from Roche. SB reports personal fees from Roche, AbbVie, Janssen, research funding from Roche, AbbVie, Celgene, Genentech, and appeared on an advisory board for Roche. MH reports research grants from Roche, Gilead, Mundipharma, Janssen, Celgene, Pharmacyclics, and Abbvie. Speakers bureau and Advisory Board for Roche, Gilead, Mundipharma, Janssen, Celgene, Pharmacyclics, Boehringer. BE reports research grants from Abbvie, Gilead, Janssen, Roche, and Beigene and personal fees, advisory boards from the same companies and Celgene and Novartis in addition.